Ticker
CIPLA
Analysis
Cipla Ltd investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to CIPLA.
Cipla Ltd investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to CIPLA.
CIPLA
Stock
$11.60B
Health Technology
Pharmaceuticals: Other
INR
Cipla Ltd may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Cipla Limited has informed the Exchange regarding a press release dated May 13, 2026.
Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin
Cipla Limited (BSE: 500087) (NSE: CIPLA-EQ) (hereafter referred to as 'Cipla') and its wholly owned subsidiary Cipla USA Inc., (hereafter referred to as 'Cipla'), today announce...
Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087) (NSE: CIPLA) (hereafter referred to as "Cipla") today announced final approval from the U.S. Food and Dr...
RESEARCH TRIANGLE PARK, N.C., March 16, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announces that it...
Review valuation context for Cipla Ltd.
Review future growth context for Cipla Ltd.
Review past performance context for Cipla Ltd.
Review financial health context for Cipla Ltd.
Review dividend context for Cipla Ltd.
Review management context for Cipla Ltd.
Review ownership context for Cipla Ltd.
Review other information context for Cipla Ltd.
Review community context for Cipla Ltd.